Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What does plasma CRP tell us about peripheral and central inflammation in depression?
Jennifer C. Felger, Ebrahim Haroon, Trusharth Patel, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 6, pp. 1301-1311
Open Access | Times Cited: 352

Showing 1-25 of 352 citing articles:

Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls
Emanuele F. Osimo, Toby Pillinger, Irene Mateos Rodríguez, et al.
Brain Behavior and Immunity (2020) Vol. 87, pp. 901-909
Open Access | Times Cited: 602
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Emanuele F. Osimo, Luke Baxter, Glyn Lewis, et al.
Psychological Medicine (2019) Vol. 49, Iss. 12, pp. 1958-1970
Open Access | Times Cited: 562
Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
Jochen Kindler, Chai K. Lim, Cynthia Shannon Weickert, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 11, pp. 2860-2872
Open Access | Times Cited: 237
Longitudinal Association Between Depression and Inflammatory Markers: Results From the Netherlands Study of Depression and Anxiety
Femke Lamers, Yuri Milaneschi, Johannes H. Smit, et al.
Biological Psychiatry (2019) Vol. 85, Iss. 10, pp. 829-837
Open Access | Times Cited: 176
Inflammation and the dimensions of depression: A review
Marzieh Majd, Erika F.H. Saunders, Christopher G. Engeland
Frontiers in Neuroendocrinology (2019) Vol. 56, pp. 100800-100800
Closed Access | Times Cited: 176
Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories
Sameer Hassamal
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 166
Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression
Roger S. McIntyre, Mehala Subramaniapillai, Yena Lee, et al.
JAMA Psychiatry (2019) Vol. 76, Iss. 8, pp. 783-783
Open Access | Times Cited: 165
Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank
Maria C. Pitharouli, Saskia P. Hagenaars, Kylie P. Glanville, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 6, pp. 522-529
Closed Access | Times Cited: 155
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?
Yuanjie Sun, Yoshihisa Koyama, Shoichi Shimada
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 154
Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Ebrahim Haroon, James R. Welle, Bobbi J. Woolwine, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 998-1007
Open Access | Times Cited: 139
Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence
Shijing Wang, Francesco Leri, Sakina J. Rizvi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 110, pp. 110289-110289
Closed Access | Times Cited: 110
Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
David R. Goldsmith, Mandakh Bekhbat, Neeti D. Mehta, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 5, pp. 405-418
Open Access | Times Cited: 108
C-Reactive Protein as a Biomarker for Major Depressive Disorder?
Laura Orsolini, Simone Pompili, Silvia Tempia Valenta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1616-1616
Open Access | Times Cited: 84
How Microbes Affect Depression: Underlying Mechanisms via the Gut–Brain Axis and the Modulating Role of Probiotics
Kazunori Suda, Kazunori Matsuda
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1172-1172
Open Access | Times Cited: 80
New and emerging approaches to treat psychiatric disorders
Katherine W. Scangos, Matthew W. State, Andrew H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 317-333
Closed Access | Times Cited: 74
Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice
Eleni Siopi, Mathieu Galerne, Manon Rivagorda, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 3002-3012
Open Access | Times Cited: 74
Inflammatory mediators in major depression and bipolar disorder
Sara Poletti, Mario Gennaro Mazza, Francesco Benedetti
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 52-68
Open Access | Times Cited: 25
Balancing the Mind: Toward a Complete Picture of the Interplay between Gut Microbiota, Inflammation and Major Depressive Disorder
Nour Dabboussi, Espérance Debs, Marc Bouji, et al.
Brain Research Bulletin (2024) Vol. 216, pp. 111056-111056
Open Access | Times Cited: 25
The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms
Jiao Wang, Jiayi Lin, Yanfang Deng, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry
Andrew H. Miller, Michael Berk, Gilles Bloch, et al.
Brain Behavior and Immunity (2025) Vol. 125, pp. 319-329
Closed Access | Times Cited: 3
The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
Charles B. Nemeroff
American Journal of Psychiatry (2020) Vol. 177, Iss. 8, pp. 671-685
Closed Access | Times Cited: 128
Molecular aspects of depression: A review from neurobiology to treatment
Gustavo Roberto Villas Boas, Roseli Boerngen de Lacerda, Marina Meirelles Paes, et al.
European Journal of Pharmacology (2019) Vol. 851, pp. 99-121
Closed Access | Times Cited: 115
The Role of Inflammation in the Treatment of Schizophrenia
Guillaume Fond, Christophe Lançon, Théo Korchia, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 113
Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far
Michael Roman, Michael R. Irwin
Brain Behavior and Immunity (2019) Vol. 83, pp. 7-21
Open Access | Times Cited: 109
Page 1 - Next Page

Scroll to top